Target and Pathway |
Top |
Target(s) |
Proto-oncogene c-Ret (RET) |
Target Info
|
Inhibitor |
[1] |
Vascular endothelial growth factor receptor 2 (KDR) |
Target Info
|
Inhibitor |
[1] |
Target's Patent Info |
Proto-oncogene c-Ret (RET) |
Target's Patent Info
|
[1] |
Vascular endothelial growth factor receptor 2 (KDR) |
Target's Patent Info
|
[1] |
KEGG Pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
Cytokine-cytokine receptor interaction
|
Endocytosis
|
PI3K-Akt signaling pathway
|
VEGF signaling pathway
|
Focal adhesion
|
Proteoglycans in cancer
|
Pathways in cancer
|
Thyroid cancer
|
Central carbon metabolism in cancer
|
NetPath Pathway
|
IL2 Signaling Pathway
|
Panther Pathway
|
Angiogenesis
|
VEGF signaling pathway
|
Pathway Interaction Database
|
HIF-2-alpha transcription factor network
|
Beta3 integrin cell surface interactions
|
Signaling events mediated by TCPTP
|
SHP2 signaling
|
S1P1 pathway
|
VEGF and VEGFR signaling network
|
Integrins in angiogenesis
|
Signaling events mediated by VEGFR1 and VEGFR2
|
Notch-mediated HES/HEY network
|
Signaling events regulated by Ret tyrosine kinase
|
Posttranslational regulation of adherens junction stability and dissassembly
|
Reactome
|
Neurophilin interactions with VEGF and VEGFR
|
VEGF binds to VEGFR leading to receptor dimerization
|
Integrin cell surface interactions
|
EPHA-mediated growth cone collapse
|
VEGFA-VEGFR2 Pathway
|
VEGFR2 mediated cell proliferation
|
WikiPathways
|
Focal Adhesion
|
Nifedipine Activity
|
Cardiac Progenitor Differentiation
|
Signaling by VEGF
|
Angiogenesis
|
SIDS Susceptibility Pathways
|
Dopaminergic Neurogenesis
|